Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Acalabrutinib cost?

See the DrugPatentWatch profile for Acalabrutinib

Acalabrutinib (brand name Calquence) cost varies a lot by country, pharmacy, insurance, and the exact dosing. Here’s a general sense for the US:

- Typical US list price for a 30‑day supply (100 mg capsules taken twice daily): about $14,000 to $22,000 per month.
- That can translate to roughly $168,000 to $264,000 per year if used continuously.
- There is no generic version yet, so costs are for the branded drug.

Out-of-pocket costs can be much lower with insurance, discount programs, or manufacturer assistance. AstraZeneca offers patient assistance and copay programs for eligible patients; uninsured or underinsured patients may qualify for additional aid.

If you’d like, tell me your country, whether you have insurance, and the exact dosing (e.g., 100 mg twice daily), and I can help estimate a more specific price and point you to potential savings programs. I can also look up current cash prices at your local pharmacies if you share a city/ZIP code.



Other Questions About Acalabrutinib :

acalabrutinib fda approval history drugs.com Acalabrutinib 100 mg price? Acalabrutinib calquence fda approval date? Acalabrutinib ema approval? Acalabrutinib maleate tablet? Acalabrutinib fda approval? Acalabrutinib fda approval date 2017 calquence?